tbuckley/cabot-search huggingface dataset:
Abstract OI: Breast Cancer in Young Women: Understanding Differences to Improve Outcomes
Authors: A Partridge
Journal: Cancer Research (2019)

Abstract Breast cancer is the leading cause of cancer related deaths in women age 40 years and younger in the United States, and a major cause of morbidity and mortality worldwide. Young women are more likely to develop more aggressive subtypes of breast cancer. Emerging data suggest the effect of age on breast cancer recurrence and death varies by tumor subtype, with young age particularly prognostic in women with ER-positive disease. Greater understanding of the biologic and genetic underpinnings of cancers that arise in younger women, potential differences in tumor and host responses including disease presenting in very premenopausal women or recently pregnant women, is critical to develop novel treatments to improve outcomes. There is also mounting evidence that access to care and behavioral differences leading to suboptimal treatment contribute to disparities in young women, including relatively poor adherence to adjuvant hormonal therapy. Prevention, detection and management of non-adherence, with attention to unique issues facing young women including desire for future fertility and pregnancy, has been the subject of recent research for this vulnerable population who, unsurprisingly, are at increased risk of psychosocial distress compared with older breast cancer survivors. Decision-support tools, and innovative, acceptable, scalable interventions to address anxiety and distress are under investigation. Finally, given that most young women will live for many decades after a diagnosis of breast cancer, it is imperative that we follow this population, in particular, over time and study their long-term, late effects in survivorship. Citation Format: Partridge A. Breast Cancer in Young Women: Understanding Differences to Improve Outcomes [abstract]. In: Proceedings of the 2018 San Antonio Breast Cancer Symposium; 2018 Dec 4-8; San Antonio, TX. Philadelphia (PA): AACR; Cancer Res 2019;79(4 Suppl):Abstract nr OI.
Next-Generation Sequencing Reveals a T Cell Receptor Signature Characteristic of Patients with Aplastic Anemia
Authors: Sofie Lundgren, Jani Huuhtanen, Mikko A Keränen, Cassandra M. Hirsch, Emmi Jokinen, Markus Heinonen, Paula Savola, Tiina Kelkka, Freja Ebeling, Jaroslaw P. Maciejewski, Eva Hellström-Lindberg, Harri Lähdesmäki, Satu Mustjoki
Journal: Blood (2018)
APPLICATION OF SYNTAX SCORE I, II AND RESIDUAL SYNTAX AS PREDICTORS OF LONG-TERM CLINICAL OUTCOMES AFTER CORONARY ARTERY BYPASS GRAFTING
Authors: Eduardo Martins, Whady Hueb, Eduardo Gomes Lima, Guilherme Fernandes Carvalho, Anderson Roberto Dallazen, Jaime Linhares Filho, Daniel Valente Batista, Rafael Silva, Diogo Freitas Cardoso Azevedo, Paulo Rezende, Jose Ramires, Roberto Kalil Filho
Journal: Journal of the American College of Cardiology (2019)
RESTING BLOOD PRESSURE IN 2881 ATHLETES AGED 9-35 YEARS OF AGE AND THE RELATION TO SEX, AGE, BODY SIZE, AND AFRO-AMERICAN DESCENT
Authors: Shadi P. Bagherzadeh, Kristofer Hedman, Jeff W. Christle, Kegan Moneghetti, Euan A. Ashley, Francois Haddad, Victor Froelicher
Journal: Journal of the American College of Cardiology (2019)
IMPAIRED MYOCARDIAL FLOW RESERVE AND LEFT VENTRICULAR REMODELING IN AORTIC STENOSIS
Authors: Wunan Zhou, Navkaranbir Bajaj, Ankur Gupta, Yee-Ping Sun, Sanjay Divakaran, Courtney Bibbo, Jon Hainer, Viviany R. Taqueti, Sharmila Dorbala, Ron Blankstein, Pinak Shah, Tsuyoshi Kaneko, Dale Adler, Patrick O'Gara, Marcelo Di Carli
Journal: Journal of the American College of Cardiology (2019)
ASSOCIATION OF REAL-TIME RADIATION MONITORING SYSTEM USE WITH RADIATION EXPOSURE AMONG PATIENTS AND PROCEDURAL PERSONNEL DURING CARDIAC CATHETERIZATION
Authors: Andrew Shin, Paulina Phomvongsa, Sheridan Reed, Sabina Shamayeva, Abbey Mulder, Stacie Vanoosterhout, Jessica Parker, Ryan Madder
Journal: Journal of the American College of Cardiology (2019)
CHARACTERIZATION BY MULTIMODALITY IMAGING OF A LARGE ANIMAL MODEL OF ISCHEMIC DILATED CARDIOMYOPATHY WITH TRANSLATIONAL IMPLICATIONS
Authors: Juan Martinez Milla, Carlos Galan-Arriola, Manuel Lobo Gonzalez, Manuel Carnero, Francisco Javier Cobiella, Jesus Mateo Castro, Jean Paul Vilchez, Beatriz Salinas, Lorena Cussó, Gonzalo Javier Lopez, Valentin Fuster, Borja Ibanez
Journal: Journal of the American College of Cardiology (2019)
MICROVASCULAR ENDOTHELIAL FUNCTION DIFFERS BETWEEN HEART FAILURE WITH PRESERVED EJECTION FRACTION PHENOTYPES
Authors: Andreas Gevaert, Birgit Boehm, Flavia Baldassarri, Inge Goovaerts, Tibor Stoop, Haley Hartmann, Stephan Mueller, Andre Duvinage, Elisabeth Kraigher-Krainer, Caroline M. Van De Heyning, Paul J. Beckers, Ulrik Wisloff, Burkert Pieske, Ephraim B. Winzer, Martin Halle, Emeline M. Van Craenenbroeck
Journal: Journal of the American College of Cardiology (2019)
PROGNOSTIC VALUE OF POST INTERVENTION FRACTIONAL FLOW RESERVE AFTER INTRAVASCULAR ULTRASOUND GUIDED SECOND GENERATION DRUG ELUTING CORONARY STENTING
Authors: Masahiro Hoshino, Yoshihisa Kanaji, Akinori Sugano, Masao Yamaguchi, Masahiro Hada, Yohei Sumino, Hiroaki Ohya, Yoshinori Kanno, Hidenori Hirano, Haruhito Yuki, Tomoki Horie, Taishi Yonetsu, Tsunekazu Kakuta
Journal: Journal of the American College of Cardiology (2019)
Abstract 473: IL-7 Increases Fusion of Rat Bone Marrow Mesenchymal Stem Cells With Cardiomyocytes In Vitro and Improve Cardiac Function In Vivo
Authors: Asmat Salim, Kanwal Haneef, Anwar Ali, Irfan Khan, Nadia Naeem
Journal: Circulation Research (2018)

Heart diseases are one of the main causes of morbidity and mortality all over the world particularly in the developing countries. Cardiac endogenous repair mechanisms have limited potential to regenerate myocardium following myocardial infarction. Mesenchymal stem cells (MSCs) hold significant promise as potential therapeutic candidates following cardiac tissue damage. Engrafted stem cells consistently experience programmed cell death and a large number of MSCs die in the ischemic area of the heart after transplantation. To ensure the survival of engrafted stem cells, it is beneficial to precondition these stem cells prior to their transplantation into the injured heart. In this study, we used interleukin-7 (IL-7), a hematopoietic growth factor having significant role in the cell survival, to transfect MSCs and observed its effect on cell-cell fusion in vitro and cardiac function in vivo . Cell fusion analyzed by co-culturing IL-7 transfected MSCs with neonatal rat cardiomyocytes (CMs) showed significantly (p&lt;0.01) higher number of fused cells as compared to that in case of normal MSCs. Transplantation of IL-7 transfected MSCs into the rat model of myocardial infarction showed improvement in the cardiac function by significantly increasing the ejection fraction (EF) and fractional shortening (FS) (p&lt;0.01), and significantly decreasing the diastolic and systolic left ventricular internal diameters (LVIDd and LVIDs) (p&lt;0.001) and end systolic and diastolic volumes (ESV and EDV) (p&lt;0.01 and p&lt;0.001 respectively) as assessed by echocardiography after 4 weeks. IL-7 is able to enhance the fusogenic properties of MSCs and improve cardiac function. This Improvement in cardiac function may be attributed to the supportive action of IL-7 on cell proliferation and cell survival contributing to the regeneration of damaged myocardium.
INFLUENCE OF SEX, ETHNICITY, AND HOSPITAL CHARACTERISTICS ON OUTCOMES IN PATIENTS WITH ATRIAL FIBRILLATION: A REPORT FROM THE NATIONAL INPATIENT SAMPLE
Authors: Sagar Ranka, Neelum Aggarwal, Charlotte Bai, Tauseef Akhtar, Sarah Alexander, Annabelle Volgman
Journal: Journal of the American College of Cardiology (2019)
Abstract 110: Numb Family Proteins Modulate Cardiac Morphogenesis by Regulating N-cadherin Trafficking to Plasma Membrane
Authors: Mingfu Wu
Journal: Circulation Research (2018)

Numb, an endocytic adaptor protein, is essential for multiple biologic processes. We previously reported that the deletion of Numb and its homologue Numblike (collectively known as, Numb Family Proteins or NFPs) specifically in heart causes a variety of morphogenetic defects, however, the key downstream target or signaling pathway that is disrupted and is responsible for each defect in the knockout was not determined. In this study, we investigated the cellular and molecular mechanisms of the trabeculation defect in the NFPs knockout. We found that during trabecular initiation, the cellular and mitotic spindle orientations of cardiomyocytes in the knockouts were significantly different from the control, which was further confirmed by the sparse cell-labeling / confetti clonal analysis. We then determined that N-Cadherin, which is required for trabecular formation in previous studies, is significantly reduced in the NFPs knockout. Genetic and biochemical tools were applied to demonstrate that Numb functions upstream of N-Cadherin and modulates its protein level to regulate trabeculation. Using chicken N-Cadherin driven by the aMHC promoter in transgenic mice, we found that cardiomyocytes that express chicken N-Cadherin in the NFPs knockout hearts preferentially localized to trabeculae compared to cardiomyocytes that do not express chicken N-Cadherin, thus partially rescuing the trabeculation defect of the knockout. This suggests that NFPs regulate trabeculation via maintaining the N-Cadherin protein level. To determine the mechanism of how NFPs regulate N-Cadherin protein, we generated a mouse line in which the endocytic motifs of Numb are deleted, and found the N-Cadherin protein level was not changed, indicating that Numb does not regulate N-Cadherin through endocytosis. Instead, we found that Numb localizes to the recycling endosome and that less N-Cadherin was localized to the membrane in the knockout, suggesting that NFPs are required for N-Cadherin recycling to the membrane. In summary, NFPs regulate N-Cadherin recycling to the plasma membrane during trabecular morphogenesis, and NFP deletion reduces N-Cadherin protein level, resulting in the trabeculation defect.
Bioactive A-ring rearranged limonoids from the root barks of Walsura robusta
Authors: Faliang An, Xiaobing Wang, Minghua Yang, Jun Luo, Lingyi Kong
Journal: Acta Pharmaceutica Sinica B (2019)

Screening active natural products, rapid identification, and accurate isolation are of great important for modern natural lead compounds discovery1. We hereby reported the isolation of seven new neotecleanin-type limonoids (1-7), seven new limonoids with 5-oxatricyclo[5.4.0.11., 4.]hendecane ring system (8-14), and two new precursors (15-16) together with four known limonoids (17-20) from the root barks of Walsura robusta. Their structures, including their absolute configurations, were elucidated based on analyses of HR-ESI-MS, 1D/2D NMR, ECD spectrum calculations and single-crystal X-ray diffraction techniques. Compounds 2, 8, 9, 11, 13, 14, 18 showed significant anti-inflammatory activities in LPS-induced RAW 264.7 cell line, BV2 microglial cells, and Propionibacterium acnes-stimulated THP-1 human monocytic cells. Walrobsin M (11) exhibited anti-inflammatory activity with IC50 value of 7.96±0.36 μmol/L, and down-regulated phosphorylation levels of ERK and p38 in a dose-dependent manner.
SHORT VERSUS TWELVE MONTHS OF DUAL ANTIPLATELET THERAPY AFTER DRUG-ELUTING STENTS IMPLANTATION: SYSTEMATIC REVIEW AND META-ANALYSIS OF RANDOMIZED CONTROLLED TRIALS
Authors: Mohamed Ayan, Mohsin Salih, Aisha Siraj, Rimsha Hasan, Sabeeda Kadavath, Fuad Habash, Aiman Smer
Journal: Journal of the American College of Cardiology (2019)
Efficacy and safety of one anastomosis gastric bypass versus Roux-en-Y gastric bypass for obesity (YOMEGA): a multicentre, randomised, open-label, non-inferiority trial
Authors: Maud Robert, Philippe Espalieu, Elise Pelascini, Robert Caiazzo, Adrien Sterkers, Lita Khamphommala, Tigran Poghosyan, Jean-Marc Chevallier, Vincent Malherbe, Elie Chouillard, Fabian Reche, Adriana Torcivia, Delphine Maucort-Boulch, Sylvie Bin-Dorel, Carole Langlois-Jacques, Dominique Delaunay, François Pattou, Emmanuel Disse
Journal: The Lancet (2019)
A CASE OF SUDDEN ONSET OF PLATYPNEA ORTHODEOXIA SYNDROME CAUSED BY TRAUMATIC TRICUSPID REGURGITATION WITH RUPTURED CHORDAE TENDINEAE AFTER BLUNT CHEST TRAUMA
Authors: Yutaka Hatani, Hidekazu Tanaka, Nao Shibata, Shun Yokota, Jun Mukai, Makiko Suto, Hiroki Takada, Fumitaka Soga, Kumiko Dokuni, Keiko Hatazawa, Eriko Hisamatsu, Kensuke Matsumoto, Ken-Ichi Hirata
Journal: Journal of the American College of Cardiology (2019)
VALIDATION OF A NOVEL MULTI-BIOMARKER PANEL FOR ACCURATE PREDICTION OF INCIDENT CARDIOVASCULAR EVENTS IN PATIENTS WITH SUSPECTED MYOCARDIAL INFARCTION
Authors: Johannes Tobias Neumann, Nils Sörensen, Tanja Zeller, Craig Magaret, Rhonda Rhyne, Grady Barnes, Celine Peters, Tau Hartikainen, Sarina Schäfer, James Januzzi, Stefan Blankenberg, Dirk Westermann
Journal: Journal of the American College of Cardiology (2019)
BETATROPHIN PREDICTS CARDIOVASCULAR EVENTS INDEPENDENTLY FROM THE PRESENCE OF TYPE 2 DIABETES AND CORONARY ARTERY DISEASE
Authors: Andreas Leiherer, Dieter Luetjohann, Axel Muendlein, Kathrin Geiger, Christoph H. Saely, Eva-Maria Brandtner, Barbara Larcher, Arthur Mader, Peter Fraunberger, Heinz Drexel
Journal: Journal of the American College of Cardiology (2019)
Abstract 17549: Impact of the Affordable Care Act on Insurance Status of Non-Elderly US Adults With Atherosclerotic Cardiovascular Disease
Authors: Haider J Warraich, Javier Valero-Elizondo, Rohan Khera, Jonathan C Hong, Joseph A Salami, Viktor Okunrintemi, Ron Blankstein, Khurram Nasir
Journal: Circulation (2017)

Background: The Affordable Care Act (ACA), passed in March 2010 and implemented in October 2013, sought to increase access to healthcare for non-elderly US adults. We sought to describe the impact ...
Abstract 16531: Acute Hyperglycemia Polarizes and Myocardial Infarction Amplifies Differential Profiles of Gene Expression in Circulating Leukocytes
Authors: Robert S Smith, Bryan A Piras, Charles R Farber, Zequan Yang, Irving L Kron, Brent A French
Journal: Circulation (2015)

Introduction: Acute hyperglycemia during MI is associated with higher clinical mortality and increased infarct size in the mouse model of reperfused MI. We used microarray analysis to compare gene expression in leukocytes isolated from normal and hyperglycemic mice after sham surgery or reperfused MI. Methods: Four treatment groups of n=4, 12 wk male C57Bl/6 mice were studied: euglycemic sham (EuSS) &amp; hyperglycemic sham (HySS) surgery, and euglycemic MI(EuMI) &amp; hyperglycemic MI (HyMI). Hyperglycemia was induced by 20% dextrose (10mL/kg) IP 20 min prior to MI. MI consisted of 30 min coronary occlusion with 2 h of reperfusion, after which mRNA was isolated from whole blood. Gene profiling was done on Illumina BeadChips using the iScan system. To verify expression patterns, 8 differentially-expressed genes were analyzed by qPCR (n=3/group). Results: Differences in gene expression were detected between EuSS, HySS &amp; EuMI mice, but none of these comparisons reached significance (all FDR ≥ 0.47). However, the EuMI vs HyMI comparison revealed a significant number of genes that were differentially regulated (241 with FDR &lt; 0.05). Differences between EuSS &amp; HySS expression were amplified (and became significant) only after MI (i.e., in the comparison between EuMI &amp; HyMI mice: Panel A). The 8 genes analyzed by qPCR were found to have a correlation of R2=0.94 with BeadChip fold change data. These genes also exemplified the pattern of gene expression under hyperglycemic conditions that became more pronounced following MI (Panel B). HEFalMp network analysis identified genes from the set of 241 with FDR &lt; 0.05 involved in regulation of T cell activation &amp; differentiation, calcium ion homeostasis, and signal transduction (p &lt; 0.05 for all). Conclusions: Hyperglycemia imparts changes in the patterns of gene expression that are amplified by MI. This altered immune response may underlie the larger infarcts in hyperglycemic mice and may contribute to higher mortality in patients with MI.
AML Cells Express Exclusively the Long Isoform of LEF1 and Are Highly Vulnerable to Blockage of LEF1-β-Catenin Binding
Authors: Kristin Feder, Katrin Elisabeth Edmaier-Schröger, Nicole Kirsten, Linda Geisdorf, Naidu Vegi, Klaus H. Metzeler, Michaela Feuring-Buske, Christian Buske
Journal: Blood (2018)
SIGNIFICANT ASSOCIATION BETWEEN TRANSBOUNDARY AIR POLLUTION AND ACUTE MYOCARDIAL INFARCTION
Authors: Kang Hao Cheong, Andrew Fu Wah Ho, Huili Zheng, Arul Earnest, Pin Pin Pek, Jeon Young Seok, Steffi Kang Ting Chan, Nan Liu, Jack Wei Chieh Tan, Ting Hway Wong, Jin Ming Koh, Derek Hausenloy, Marcus Eng Hock Ong
Journal: Journal of the American College of Cardiology (2019)
SUCCESSFUL ULTRASOUND ASSISTED CATHETER-DIRECTED THROMBOLYSIS COMPLICATED WITH RENAL AND HEPATIC FAILURE IN MASSIVE PULMONARY EMBOLISM OCTOGENARIAN PATIENT
Authors: José Gildardo Paredes-Vázquez, Carlos Sanchez-Diaz, Felipe Valdes, Luis Manautou, Vicente Jimenez Franco, Mauricio Vázquez-Guajardo, Mariana Vanoye-Tamez, Raúl Del Toro-Mijares
Journal: Journal of the American College of Cardiology (2019)
IMMEDIATE VERSUS DELAYED REVASCULARIZATION IN PATIENTS WITH TRANSIENT ST-ELEVATION MYOCARDIAL INFARCTION: 1-YEAR FOLLOW-UP OF THE RANDOMIZED CLINICAL TRANSIENT TRIAL
Authors: Gladys Janssens, Jorrit Lemkes, Nina van der Hoeven, Peter van de Ven, Koen Marques, Alexander Nap, Maarten Van Leeuwen, Yolande Appelman, Paul Knaapen, Cornelius Verouden, Cornelis Allaart, Stijn Brinckman, Colette Saraber, Koos Plomp, Jorik Timmer, Elvin Kedhi, Rik Hermanides, Martijn Meuwissen, Jeroen Schaap, Arno Van Der Weerdt, Albert van Rossum, Robin Nijveldt, Niels Van Royen
Journal: Journal of the American College of Cardiology (2019)
Fevipiprant, a selective prostaglandin D2 receptor 2 antagonist, inhibits human group 2 innate lymphoid cell aggregation and function
Authors: Clare Hardman, Wentao Chen, Jian Luo, Paul Batty, Yi-Ling Chen, Janina Nahler, Yanqiu Wu, Ian D. Pavord, Veit J. Erpenbeck, David A. Sandham, Luzheng Xue, Graham Ogg
Journal: Journal of Allergy and Clinical Immunology (2019)
Guide RNAs with embedded barcodes boost CRISPR-pooled screens
Authors: Shiyou Zhu, Zhongzheng Cao, Zhiheng Liu, Yuan He, Yinan Wang, Pengfei Yuan, Wei Li, Feng Tian, Ying Bao, Wensheng Wei
Journal: Genome biology (2019)

We report a new method using re-designed guide RNAs with internal barcodes (iBARs) embedded in their loop regions. Our iBAR approach outperforms the conventional method by producing screening results with much lower false-positive and false-negative rates especially with a high multiplicity of infection (MOI). Importantly, the iBAR approach reduces the starting cells at high MOI significantly with greatly improved efficiency and accuracy compared with the canonical CRISPR screens at a low MOI. This new system is particularly useful when the source of cells is limited or when it is difficult to control viral infection for in vivo screening.
THE ASSOCIATION AMONG DEPRESSIVE SYMPTOMS, EMOTIONAL STATUS, AND CAROTID ATHEROSCLEROTIC BURDEN OF THE CORINTHIA STUDY POPULATION
Authors: Sotirios Tsalamandris, Evangelos Oikonomou, George Lazaros, Evangelia Christoforatou, Georgia Vogiatzi, Effimia Zacharia, Christos Chasikidis, Athina Goliopoulou, George-Angelo Papamikroulis, Charilila-Loukia Ververeli, Maria Anastasiou, Nikolaos Galiatsatos, Dimitris Tousoulis
Journal: Journal of the American College of Cardiology (2019)
EFFICACY OF A CENTRALIZED, BLENDED ELECTRONIC, AND HUMAN INTERVENTION TO IMPROVE DOAC ADHERENCE: THE SMARTADHERE TRIAL
Authors: Mintu P. Turakhia, Vandana Sundaram, Shea Smith, Victoria Ding, P. Michael Ho, Peter R. Kowey, Jonathan Piccini, JoAnne Foody, Mary Birmingham, Juliana Ianus, Amol Rajmane, Kenneth Mahaffey
Journal: Journal of the American College of Cardiology (2019)
A META-ANALYSIS OF RANDOMIZED TRIALS COMPARING LONG-TERM (5-YEAR) SAFETY AND EFFICACY OF BIODEGRADABLE POLYMER DRUG-ELUTING STENTS WITH NEW GENERATION DURABLE POLYMER DRUG-ELUTING STENTS
Authors: Khalid Najib, Farhan Ashraf, Babar Khan, Aranyak Rawal, Rahman Shah
Journal: Journal of the American College of Cardiology (2019)
VARIATIONS IN QUALITY MEASURE COMPLIANCE IN PRESCRIPTIONS FOR ATRIAL FIBRILLATION PATIENTS AMONG OUTPATIENT CARDIOLOGY PRACTICES: INSIGHTS FROM THE NCDR PINNACLE REGISTRY®
Authors: Jonathan Chong Hsu, Matthew Reynolds, Yang Song, Gheorghe Doros, Steven Lubitz, Anil Gehi, Mintu Turakhia, Thomas Maddox
Journal: Journal of the American College of Cardiology (2019)
PREDICTORS OF LONG TERM (&gt;10 YEAR) SURVIVAL AFTER CRT PLACEMENT
Authors: Divyang Patel, Kevin Trulock, Saleem Toro, Laurie Ann Moennich, Erich Kiehl, Anirudh Kumar, Adam Grimaldi, Eiran Gorodeski, Mark Niebauer, Bruce Wilkoff, Niraj Varma, John Rickard
Journal: Journal of the American College of Cardiology (2019)
COMPARATIVE EFFECTIVENESS OF APIXABAN VERSUS WARFARIN FOR TREATMENT OF VENOUS THROMBOEMBOLISM IN PATIENTS WITH AND WITHOUT ACTIVE CANCER
Authors: Gail D. Wygant, Jennifer Guo, Lisa Rosenblatt, Derek Weycker, Shawn Li, Theodore Lee, Xuemei Luo, Jack Mardekian, Ahuva Hanau, Mark Atwood, Xianying Pan, Alexander (Ander) Cohen
Journal: Journal of the American College of Cardiology (2019)
Correction: High expression of HMGA2 independently predicts poor clinical outcomes in acute myeloid leukemia
Authors: Miriam Marquis, Cyrielle Beaubois, Vincent-Philippe Lavallée, Michal Abrahamowicz, Coraline Danieli, Sébastien Lemieux, Imran Ahmad, Andrew Wei, Stephen B. Ting, Shaun Fleming, Anthony Schwarer, David Grimwade, William Grey, Robert K. Hills, Paresh Vyas, Nigel Russell, Guy Sauvageau, Josée Hébert
Journal: Blood Cancer Journal (2019)

Since the publication of the original article the authors noticed the the affiliation details for Paresh Vyas are incorrect. The correct affiliation details for this author are given below:
Characterization of Cardiovascular Adverse Events and B-Type Natriuretic Peptide Levels in Patients with Multiple Myeloma Who Are Treated with Carfilzomib
Authors: Hang Quach, Khue Minh Nguyen, Matthew Ku, Ali Bazargan, Robin J Filshie, Constantine S. Tam, Lisa Catherine Demosthenous, David Prior
Journal: Blood (2018)
Abstract 17661: Wide Variability in Emergency Department Disposition of Patients With Atrial Fibrillation and Flutter in a U.S. Integrated Healthcare Delivery System
Authors: Bory Kea, E. Margaret M Warton, Mary E Reed, Adina S Rauchwerger, Dustin W Ballard, David R Vinson
Journal: Circulation (2017)

Introduction: Multi-national rates of hospitalization for atrial fibrillation and flutter (AFF) from the emergency department (ED) vary widely without clear evidence-based predictors of high-risk patients who need hospitalization. Objective: To determine facility variability in AFF hospitalization rates and predictors of admission in AFF patients in a U.S. integrated health system. Methods: In a multi-center prospective observational study, treating physicians enrolled a convenience sample of non-anticoagulated adult member evaluated for AFF in 7 Kaiser Permanente urban community EDs with 24/7 on-call cardiology from 05/2011 to 08/2012. Data collected included presenting symptoms, characterization of the dysrhythmia, comorbidities, ED management, and discharge rhythm and pharmacotherapy. Additional demographic and clinical variables, including CHA2DS2-VASc and HAS-BLED, were extracted from the electronic health record. We compared characteristics between those hospitalized and not hospitalized, using univ...
POST PCI HEMODYNAMICS: PREDICTIVE ACCURACY OF POST STENTING PD/PA FOR DETERMINING POST STENTING ISCHEMIA
Authors: Linle Hou, Srikanth Kasula, Shiv Kumar Agarwal, Yalcin Hacioglu, Bobby Ghosh, Sabha Bhatti, Barry Uretsky, Abdul Hakeem
Journal: Journal of the American College of Cardiology (2019)
INCIDENCE AND RISK FACTORS FOR IMPLANTATION OF A CARDIAC ELECTRONIC DEVICE FOLLOWING MITRAL OR AORTIC VALVE SURGERY
Authors: Gil Moskowitz, Kimberly Hong, Gennaro Giustino, A. Gillinov, Joseph DeRose, Gorav Ailawadi, Alexander Iribarne, Alan Moskowitz, Annetine Gelijns, Natalia Egorova
Journal: Journal of the American College of Cardiology (2019)